These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30703501)

  • 1. Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment.
    Bastiancich C; Bozzato E; Luyten U; Danhier F; Bastiat G; Préat V
    Int J Pharm; 2019 Mar; 559():220-227. PubMed ID: 30703501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.
    Bastiancich C; Vanvarenberg K; Ucakar B; Pitorre M; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2016 Mar; 225():283-93. PubMed ID: 26829100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models.
    Bastiancich C; Lemaire L; Bianco J; Franconi F; Danhier F; Préat V; Bastiat G; Lagarce F
    Nanomedicine (Lond); 2018 Aug; 13(16):1999-2013. PubMed ID: 30204064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
    Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells.
    Bozzato E; Tsakiris N; Paquot A; Muccioli GG; Bastiancich C; Préat V
    Int J Pharm; 2022 Nov; 628():122341. PubMed ID: 36341916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
    Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
    Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure.
    Moysan E; González-Fernández Y; Lautram N; Béjaud J; Bastiat G; Benoit JP
    Soft Matter; 2014 Mar; 10(11):1767-77. PubMed ID: 24652455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
    Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
    Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature and pH-responsive in situ hydrogels of gelatin derivatives to prevent the reoccurrence of brain tumor.
    Kang JH; Turabee MH; Lee DS; Kwon YJ; Ko YT
    Biomed Pharmacother; 2021 Nov; 143():112144. PubMed ID: 34509823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
    Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
    Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.
    Zhao M; Bozzato E; Joudiou N; Ghiassinejad S; Danhier F; Gallez B; Préat V
    J Control Release; 2019 Sep; 309():72-81. PubMed ID: 31306678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.
    Gaudin A; Song E; King AR; Saucier-Sawyer JK; Bindra R; Desmaële D; Couvreur P; Saltzman WM
    Biomaterials; 2016 Oct; 105():136-144. PubMed ID: 27521616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy.
    Sasso MS; Lollo G; Pitorre M; Solito S; Pinton L; Valpione S; Bastiat G; Mandruzzato S; Bronte V; Marigo I; Benoit JP
    Biomaterials; 2016 Jul; 96():47-62. PubMed ID: 27135716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering.
    Chakroun RW; Wang F; Lin R; Wang Y; Su H; Pompa D; Cui H
    ACS Nano; 2019 Jul; 13(7):7780-7790. PubMed ID: 31117370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.
    Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L
    Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer.
    Liang Y; Tian B; Zhang J; Li K; Wang L; Han J; Wu Z
    Int J Nanomedicine; 2017; 12():1699-1715. PubMed ID: 28280336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine and glioblastoma: challenges and current perspectives.
    Bastiancich C; Bastiat G; Lagarce F
    Drug Discov Today; 2018 Feb; 23(2):416-423. PubMed ID: 29074439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.